221 related articles for article (PubMed ID: 16737551)
41. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
[TBL] [Abstract][Full Text] [Related]
42. Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma.
Straume O; Akslen LA
Br J Cancer; 2005 Oct; 93(8):933-8. PubMed ID: 16189525
[TBL] [Abstract][Full Text] [Related]
43. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of Eph receptor and ephrin expression within the human cornea and limbus.
Hogerheyde TA; Stephenson SA; Harkin DG; Bray LJ; Madden PW; Woolf MI; Richardson NA
Exp Eye Res; 2013 Feb; 107():110-20. PubMed ID: 23247085
[TBL] [Abstract][Full Text] [Related]
45. Receptor-binding domain of ephrin-A1: production in bacterial expression system and activity.
Nekrasova OV; Sharonov GV; Tikhonov RV; Kolosov PM; Astapova MV; Yakimov SA; Tagvey AI; Korchagina AA; Bocharova OV; Wulfson AN; Feofanov AV; Kirpichnikov MP
Biochemistry (Mosc); 2012 Dec; 77(12):1387-94. PubMed ID: 23244735
[TBL] [Abstract][Full Text] [Related]
46. Nanoscale obstacle arrays frustrate transport of EphA2-Ephrin-A1 clusters in cancer cell lines.
Lohmüller T; Xu Q; Groves JT
Nano Lett; 2013 Jul; 13(7):3059-64. PubMed ID: 23668885
[TBL] [Abstract][Full Text] [Related]
47. Protection by the Eph-Ephrin System Against Mesenteric Ischemia-Reperfusion Injury.
Vivo V; Zini I; Cantoni AM; Grandi A; Tognolini M; Castelli R; Ballabeni V; Bertoni S; Barocelli E
Shock; 2017 Dec; 48(6):681-689. PubMed ID: 28472014
[TBL] [Abstract][Full Text] [Related]
48. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction.
Goichberg P; Bai Y; D'Amario D; Ferreira-Martins J; Fiorini C; Zheng H; Signore S; del Monte F; Ottolenghi S; D'Alessandro DA; Michler RE; Hosoda T; Anversa P; Kajstura J; Rota M; Leri A
Circ Res; 2011 Apr; 108(9):1071-83. PubMed ID: 21415392
[TBL] [Abstract][Full Text] [Related]
49. EPHA2/EFNA1 expression in human gastric cancer.
Nakamura R; Kataoka H; Sato N; Kanamori M; Ihara M; Igarashi H; Ravshanov S; Wang YJ; Li ZY; Shimamura T; Kobayashi T; Konno H; Shinmura K; Tanaka M; Sugimura H
Cancer Sci; 2005 Jan; 96(1):42-7. PubMed ID: 15649254
[TBL] [Abstract][Full Text] [Related]
50. Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
Brantley-Sieders DM; Jiang A; Sarma K; Badu-Nkansah A; Walter DL; Shyr Y; Chen J
PLoS One; 2011; 6(9):e24426. PubMed ID: 21935409
[TBL] [Abstract][Full Text] [Related]
51. Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells.
Jellinghaus S; Poitz DM; Ende G; Augstein A; Weinert S; Stütz B; Braun-Dullaeus RC; Pasquale EB; Strasser RH
Biochim Biophys Acta; 2013 Oct; 1833(10):2201-11. PubMed ID: 23707953
[TBL] [Abstract][Full Text] [Related]
52. Excitatory Eph receptors and adhesive ephrin ligands.
Klein R
Curr Opin Cell Biol; 2001 Apr; 13(2):196-203. PubMed ID: 11248553
[TBL] [Abstract][Full Text] [Related]
53. A review on the role of different ephrins in glioma.
Zhu B; Li Y; Mao X
Eur J Pharmacol; 2022 Feb; 917():174588. PubMed ID: 34688637
[TBL] [Abstract][Full Text] [Related]
54. Auditory brainstem responses of ephrin-A2, ephrin-A5(-/-) and ephrin-A2A5(-/-) mice.
Yates N; Robertson D; Martin-Iverson M; Rodger J
Audiol Neurootol; 2014; 19(2):115-26. PubMed ID: 24457350
[TBL] [Abstract][Full Text] [Related]
55. Distinctive Structure of the EphA3/Ephrin-A5 Complex Reveals a Dual Mode of Eph Receptor Interaction for Ephrin-A5.
Forse GJ; Uson ML; Nasertorabi F; Kolatkar A; Lamberto I; Pasquale EB; Kuhn P
PLoS One; 2015; 10(5):e0127081. PubMed ID: 25993310
[TBL] [Abstract][Full Text] [Related]
56. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis.
Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S
Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989
[TBL] [Abstract][Full Text] [Related]
57. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Fukuchi M; Nakajima M; Kuwano H
Int J Cancer; 2003 Feb; 103(5):657-63. PubMed ID: 12494475
[TBL] [Abstract][Full Text] [Related]
58. Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.
Makarov A; Ylivinkka I; Nyman TA; Hyytiäinen M; Keski-Oja J
Cell Biol Int; 2013 Oct; 37(10):1080-8. PubMed ID: 23686814
[TBL] [Abstract][Full Text] [Related]
59. Ephrin stimulation modulates T cell chemotaxis.
Sharfe N; Freywald A; Toro A; Dadi H; Roifman C
Eur J Immunol; 2002 Dec; 32(12):3745-55. PubMed ID: 12516569
[TBL] [Abstract][Full Text] [Related]
60. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.
Fox BP; Kandpal RP
Biochem Biophys Res Commun; 2004 Jun; 318(4):882-92. PubMed ID: 15147954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
